Beneficial Effects of Torasemide on Systolic Wall Stress and Sympathetic Nervous Activity in Asymptomatic or Mildly Symptomatic Patients With Heart Failure: Comparison With Azosemide
Authors:
- Ken HaradaKHKen Harada
- Hideo IzawaHIHideo Izawa
- Takao NishizawaTNTakao Nishizawa
- Akihiro HirashikiAHAkihiro Hirashiki
- Yosuke MuraseYMYosuke Murase
- Masakazu KobayashiMKMasakazu Kobayashi
- Satoshi IsobeSISatoshi Isobe
- Xian Wu ChengXCXian Wu Cheng
- Akiko NodaANAkiko Noda
- Kohzo NagataKNKohzo Nagata
- Mitsuhiro YokotaMYMitsuhiro Yokota
- Toyoaki MuroharaTMToyoaki Murohara
- 1 June 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 53 (6) , 468-473
Abstract
Loop diuretics could adversely influence prognosis due to activation of neurohumoral mechanism in the long term. Previous study showed torasemide, a loop diuretic with anti-aldosteronergic properties, was associated with lower mortality in patients with chronic heart failure (CHF). We evaluated the effects of torasemide, in comparison with azosemide, in patients with CHF. Patients received oral diuretic therapy with torasemide (8 mg/d, n = 15) or azosemide (60 mg/d, n = 15) for 3 months. Torasemide and azosemide were then switched, and the patients were treated for another 3 months. Torasemide treatment induced significant decreases in left ventricular (LV) systolic wall stress (from 259 ± 95 to 232 ± 80 kdyn/cm2) and the plasma level of aldosterone (from 133 ± 61 to 95 ± 50 pg/mL) and was not associated with a change in the plasma level of norepinephrine. In contrast, the plasma level of norepinephrine was significantly increased (from 370 ± 170 to 481 ± 247 pg/mL), whereas LV systolic wall stress was unchanged after azosemide treatment. This study indicates that torasemide treatment reduced LV systolic wall stress without activation of the sympathetic nervous system in patients with CHF. The anti-aldosteronergic properties of torasemide may contribute to its favorable effects.Keywords
This publication has 30 references indexed in Scilit:
- Diuretic Use, Progressive Heart Failure, and Death in Patients in the DIG StudyJournal of Cardiac Failure, 2006
- Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model ratsCardiovascular Research, 2005
- The Polymorphonuclear Leukocyte and the Abdominal Aortic AneurysmCirculation, 2005
- Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)European Heart Journal, 2005
- Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure SurveyEuropean Heart Journal, 2004
- Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)JACC, 2003
- Torasemide in Chronic Heart Failure: Results of the TORIC StudyEuropean Journal of Heart Failure, 2002
- Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failureThe American Journal of Medicine, 2001
- Comparison of Neurohumoral Effects of Short-Acting and Long-Acting Loop Diuretics in Patients with Chronic Congestive Heart FailureJournal of Cardiovascular Pharmacology, 2001
- Diuretic TherapyNew England Journal of Medicine, 1998